MedTrace Logo

The Effect of Folic Acid on Efficacy of Sulfadoxine-pyrimethamine in Pregnant Women in Western Kenya

NCT00130065 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 600

Last updated 2012-09-27

No results posted yet for this study

Summary

The purpose of this study is to determine whether folic acid, which is often routinely given to pregnant women to prevent birth defects and anemia, affects the efficacy of sulfadoxine-pyrimethamine, another drug that is routinely given to pregnant women in highly malarious areas, for prevention of the adverse effects of malaria during pregnancy.

Conditions

Interventions

DRUG

Sulfadoxine-pyrimethamine/folic acid

DRUG

Sulfadoxine-pyrimethamine/placebo

Sponsors & Collaborators

Principal Investigators

  • Annemieke Van Eijk, M.D., Ph.D. · Centers for Disease Control and Prevention, Kenya Medical Research Institiute

  • Monica Parise, M.D. · Centers for Disease Control and Prevention

  • Laurence Slutsker, M.D. · Centers for Disease Control and Prevention, Kenya Medical Research Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
15 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-11-30
Primary Completion
2006-02-28
Completion
2006-02-28

Countries

  • Kenya

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00130065 on ClinicalTrials.gov